Wong's Kong King International (Holdings) First Half 2025 Earnings: HK$0.015 loss per share (vs HK$0.12 loss in 1H 2024)
Wong's Kong King International (Holdings) (HKG:532) First Half 2025 Results
Key Financial Results
- Revenue: HK$1.82b (up 8.3% from 1H 2024).
- Net loss: HK$11.0m (loss narrowed by 87% from 1H 2024).
- HK$0.015 loss per share (improved from HK$0.12 loss in 1H 2024).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Wong's Kong King International (Holdings)'s share price is broadly unchanged from a week ago.
Risk Analysis
Before we wrap up, we've discovered 2 warning signs for Wong's Kong King International (Holdings) (1 is potentially serious!) that you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Wong's Kong King International (Holdings) might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:532
Wong's Kong King International (Holdings)
An investment holding company, trades in and distributes chemicals, materials, and equipment used in the manufacturing of printed circuit boards and electronic products in North America, Europe, Hong Kong, China, Taiwan, and internationally.
Mediocre balance sheet with low risk.
Market Insights
Weekly Picks

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Adobe: A Probabilistic Case for Undervaluation

A Capital Allocation Favorite with Structural Importance

Good foundation, but now it's all about the next steps
Recently Updated Narratives
NOW is an established SAAS positioned for accelerated growth over the next 5 years.

Nilai Wajar di Tengah Pemulihan Kinerja

Making sense of 1.75 trillion IPO
Popular Narratives

Investment Analysis (May 2026)

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

